2026 Development and External Validation of a Machine Learning-Based Risk Classification Score for Prostate Cancer-Specific Cardiovascular Risk. Nickolas Stabellini, Tarek Nahle, Viraj Shah, Sai S. Kollapaneni, Omar M. Makram, Jennifer Cullen, Neal L. Weintraub, Harikrishnan H. Kunhiraman, Umang Swami, Morteza Mahmoudi, Nathanael Fillmore, Isla P. Garraway, Darryl Leong, Jehonathan Pinthus, John Shanahan, Alberto J. Montero, Neeraj Agarwal, Avirup Guha JCO Oncology PracticeOP2600131 Prostate Cancer Cardiovascular Disease Cardio-Oncology Machine Learning Predictive Modeling
2026 Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance. Matthew R. Cooperberg†, John R. Bihn†, John M. Culnan, Jennifer La, Sergey D. Goryachev, Daniel C. R. Chen, Oleg Soloviev, Grace Lee, June K. Corrigan, Kaitlin N. Swinnerton, Nicholas G. Nickols, Karlynn N. Dulberger, Pedro Barata, Rhonda L. Bitting, Mary T. Brophy, Heather H. Cheng, Hoedt Amanda De, Nhan V. Do, Stephen J. Freedland, Isla P. Garraway, J. Michael Gaziano, Susan Halabi, Richard L. Hauger, Stacy Loeb, David M. Nanus, Timothy R. Rebbeck, Matthew B. Rettig, Chong-Xian Pan, Kenute Myrie, Rachel B. Ramoni, Nathanael R. Fillmore‡, Channing J. Paller‡† Equal first authorship · ‡ Equal senior authorship JAMA Oncology12(1), 111-113 U.S. Veterans and VA Data Retrospective Cohort Study Electronic Health Records Prostate Cancer Active Surveillance
